CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
VIRGINIA BEACH, Va. — After years of meetings, rallies, lawsuits, and neighborhood forums, Virginia Beach voters went to the polls on Tuesday to decide how their city council is elected. A referendum ...
Brightgene Bio-Medical Technology Co. Ltd. has patented new calcitonin receptor (CALCR; CT-R) and amylin AMY3 receptor agonists potentially useful for the treatment of obesity and metabolic disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results